Dynavax Technologies | Attività Correnti





Attività Correnti Cambiamento Data
AbbVie USD 28.54B 722M 2025-09
Adma Biologics USD 402.66M 3.1M 2025-09
Agenus USD 133.95M 120.61M 2025-09
Amgen USD 29.06B 1.17B 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Dynavax Technologies USD 814.33M 28.62M 2025-09
Gilead Sciences USD 19.89B 1.05B 2025-12
Glaxosmithkline GBP 23.98B 6.31B 2025-09
Merck USD 47.56B 10.49B 2025-09
Minerva Neurosciences USD 13.02M 2.53M 2025-09
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
Novartis USD 28.2B 2.26B 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
TG Therapeutics USD 599.76M 64.2M 2025-09
Vertex Pharmaceuticals USD 10.57B 141.7M 2025-09


Dynavax Technologies Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.